Personalized Investing and
Digital Wealth Optimization
Asset Comparison and Correlation |
|
|
| NYSE vs Biotest AG |
Given investment horizon of 30 days, NYSE is expected to generate 0.69 times more return on investment than Biotest. However, NYSE is 1.45 times less risky than Biotest. It trades about -0.15 of its potential returns per unit of risk. Biotest AG is currently generating about -0.27 per unit of risk. If you would invest 959,827 in NYSE on May 19, 2013 and sell it today you would lose (26,038) from holding NYSE or give up 2.71% of portfolio value over 30 days. |
Follow Correlation between NYA and BIO with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker
|
Match-ups for NYSE |
Over the last 30 days Biotest AG has generated negative risk-adjusted returns adding no value to investors with long positions. Match-ups for Biotest
|
| Frequently Asked Questions Quick Product Tour Product Technology Overview Solution Methodology Plans and Pricing |
|
World Market Correlations Instant Equity Comparator Watchlist Analysis Position Suggestions Equity Alpha Analysis |
|
About Macroaxis Contact Us Product Terms Of Use Service Privacy Policy Advertising Opportunities |
0.78% 
Select Assests
Optimize Portfolio
Suggest Portfolio
Backtest Watchlist
Analyze Correlations
View Transactions
Check Volatilities
Import Equities
Search Equities
